DC cardioversion

Clinical trials for DC cardioversion explained in plain language.

Never miss a new study

Get alerted when new DC cardioversion trials appear

Sign up with your email to follow new studies for DC cardioversion, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Can a diabetes drug keep the heart in rhythm?

Disease control Recruiting now

This trial tests whether giving an SGLT2 inhibitor (dapagliflozin or empagliflozin) after a successful electrical cardioversion can help prevent atrial fibrillation from returning in people who also have heart failure with preserved ejection fraction. Participants will be randoml…

Matched conditions: DC CARDIOVERSION

Phase 4 • Sponsor: Samsung Medical Center • Aim: Disease control

Last updated Aug 22, 2026 00:00 UTC

DC cardioversion

Get alerted when new DC cardioversion trials appear

Can a diabetes drug keep the heart in rhythm?